Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence



Rating:

Share or cite this content

Citations should be made in the following way:
E. Metting (Groningen, Netherlands), J. Kracht (Groningen, Netherlands), R. Dekhuijzen (Nijmegen, Netherlands). The economic impact recurrent inhaler versus single instructions in asthma and COPD patients. 4285

Member's Comments

No comment yet.

Related content which might interest you: The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique? Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Differences in inhaler misuse between patients with asthma and COPD. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Investigating the percentage of patients with COPD who could benefit from a change in inhaler Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Influence of treatment by single combined inhaler on adherence of patients with asthma Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Hair analysis to detect chronic inhaler drug use in asthma or COPD patients Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 The importance of inhaler technique education in asthma and COPD: a long-term follow-up Source: International Congress 2019 – Medical education Year: 2019 Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations? Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activities Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Evaluation of adherence of patients with asthma to treatment by single combination inhaler Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Asthma and COPD patient characteristics and illness perceptions related to inhaler technique Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Description of the UK’s asthma and COPD inhaler use Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021 What influences the response to training of inhalation technique in patients with asthma and COPD? Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018